This analysis indicated that the best pipelines’ chances of classifying a patient with MHT increased in conjunction with elevated BPs, body weight, body surface area, LV mass/thickness, and several biochemical markers (DHEA-S, chromium, human sex hormone-binding globulin). The gene discussed is SHBG; the disease is malignant hypertension.